Found 16 matching trials
BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus PHASE3 The purpose of this study is to assess the weight loss effect of lorcaserin...
Show More Location
Arena Pharmaceuticals, Inc.
Learn More & Join Trial
Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy PHASE2 A Randomized Phase II study Comparing Lorcaserin versus Duloxetine for the ...
Show More Location
Cancer Treatment Centers of America - Atlanta
Learn More & Join Trial
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors PHASE4 This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Show More Location
Advanced Cardiovascular, LLC
Learn More & Join Trial
To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake PHASE1 The purpose of this study is to evaluate the effect of lorcaserin on energy...
Show More Location
Pennington Biomedical Research Center
Learn More & Join Trial
Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer PHASE1 This phase I trial studies how well lorcaserin works in treating chemothera...
Show More Location
Multiple Locations
Learn More & Join Trial
BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management PHASE3 The purpose of this study is to assess the weight loss effect of lorcaserin...
Show More Location
Arena Pharmaceuticals, Inc.
Learn More & Join Trial
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation PHASE2 In smokers who are motivated to stop smoking, treatment with lorcaserin com...
Show More Location
Pharmacology Research Institute
Learn More & Join Trial
Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.) N/A The fixed-dose combination of naltrexone 8mg and bupropion 90mg extended-re...
Show More Location
Currax Pharmaceuticals
Learn More & Join Trial
A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age PHASE1 Study will evaluate the pharmacokinetics (PK), safety and tolerability of a...
Show More Location
Anaheim Clinical Trials
Learn More & Join Trial
Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age PHASE1 The purpose of this study is to evaluate the PK properties, tolerability, a...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial